SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-016726
Filing Date
2022-03-31
Accepted
2022-03-31 16:02:03
Documents
93
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_abvcbio.htm   iXBRL 10-K 2318602
2 BYLAWS OF THE COMPANY, AS AMENDED f10k2021ex3-2_abvcbiopharma.htm EX-3.2 110403
3 CERTIFICATION f10k2021ex31-1_abvcbiopharma.htm EX-31.1 10782
4 CERTIFICATION f10k2021ex31-2_abvcbiopharma.htm EX-31.2 10902
5 CERTIFICATION f10k2021ex32-1_abvcbiopharma.htm EX-32.1 4596
6 CERTIFICATION f10k2021ex32-2_abvcbiopharma.htm EX-32.2 4512
7 GRAPHIC image_001.jpg GRAPHIC 21663
8 GRAPHIC image_002.jpg GRAPHIC 8620
  Complete submission text file 0001213900-22-016726.txt   9483644

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE abvc-20211231.xsd EX-101.SCH 96353
10 XBRL CALCULATION FILE abvc-20211231_cal.xml EX-101.CAL 46540
11 XBRL DEFINITION FILE abvc-20211231_def.xml EX-101.DEF 376875
12 XBRL LABEL FILE abvc-20211231_lab.xml EX-101.LAB 712167
13 XBRL PRESENTATION FILE abvc-20211231_pre.xml EX-101.PRE 393042
87 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_abvcbio_htm.xml XML 1172494
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40700 | Film No.: 22792288
SIC: 2834 Pharmaceutical Preparations